{"entity":{"id":"kristina-lang","kind":"person","name":"Kristina Lång","aka":[],"tldr":"Led MASAI, the first randomised trial of AI-supported mammography screening, which found more cancers with half the radiologist workload.","summary":"Kristina Lång is principal investigator of MASAI, the Swedish randomised trial of 100,000 women showing that AI-supported screen reading detects 29% more cancers than standard double reading while cutting radiologist workload by 44%, without increasing false positives. She also led the Malmö Breast Tomosynthesis Screening Trial. Her work is the strongest evidence yet for deploying AI in population screening.","asOf":"2026-09-10","links":[{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Lang%20K%5BAuthor%5D%20mammography%20artificial%20intelligence"}],"tags":["screening","ai","breast","sweden"],"related":[],"cancers":["breast-hr-positive"],"sections":[],"technologies":["radiology-ai-screening","mammography"],"targets":[],"drugs":[],"companies":[],"institutions":["lund-skane"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":["paper-masai-lancet-oncol-2023"],"journals":[],"dependsOn":[],"notes":[],"role":"Associate Professor of Diagnostic Radiology, Lund University; Breast Radiologist, Skåne University Hospital","institutionId":"lund-skane","specialisms":["Breast imaging","AI in mammography screening","Screening trials","Digital breast tomosynthesis"],"profiles":[{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Lang%20K%5BAuthor%5D%20mammography%20artificial%20intelligence"}],"papers":[{"title":"Artificial intelligence-supported screen reading versus standard double reading in the Mammography Screening with Artificial Intelligence trial (MASAI): a clinical safety analysis of a randomised, controlled, non-inferiority, single-blinded, screening accuracy study","journal":"Lancet Oncology","year":2023,"doi":"10.1016/S1470-2045(23)00298-X"},{"title":"Screening performance of digital breast tomosynthesis vs digital mammography in the Malmö Breast Tomosynthesis Screening Trial","journal":"Lancet Oncology","year":2018,"doi":"10.1016/S1470-2045(18)30610-0"}]},"route":"/people/kristina-lang/","neighbours":{"cancer":[{"id":"breast-hr-positive","kind":"cancer","name":"HR-positive / HER2-negative breast cancer","route":"/cancers/breast-hr-positive/"}],"technology":[{"id":"radiology-ai-screening","kind":"technology","name":"AI in radiology","route":"/technologies/radiology-ai-screening/"},{"id":"mammography","kind":"technology","name":"Mammography & tomosynthesis","route":"/technologies/mammography/"}],"institution":[{"id":"lund-skane","kind":"institution","name":"Skåne University Hospital / Lund University Cancer Centre","route":"/institutions/lund-skane/"}],"paper":[{"id":"paper-masai-lancet-oncol-2023","kind":"paper","name":"MASAI: AI-supported mammography screening finds more cancers with half the radiologist workload","route":"/key-papers/paper-masai-lancet-oncol-2023/"}]}}